PortalPublikationenEffects of bortezomib on human neuroblastoma cells in vitro ...

Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model.

Standard

Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model. / Valentiner, Ursula; Haane, Christina; Nehmann, Nina; Schumacher, Udo.

in: ANTICANCER RES, Jahrgang 29, Nr. 4, 4, 2009, S. 1219-1225.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Valentiner, U, Haane, C, Nehmann, N & Schumacher, U 2009, 'Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model.', ANTICANCER RES, Jg. 29, Nr. 4, 4, S. 1219-1225. <http://www.ncbi.nlm.nih.gov/pubmed/19414367?dopt=Citation>

APA

Valentiner, U., Haane, C., Nehmann, N., & Schumacher, U. (2009). Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model. ANTICANCER RES, 29(4), 1219-1225. [4]. http://www.ncbi.nlm.nih.gov/pubmed/19414367?dopt=Citation

Vancouver

Valentiner U, Haane C, Nehmann N, Schumacher U. Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model. ANTICANCER RES. 2009;29(4):1219-1225. 4.

Bibtex

@article{6448969642a34deaacd4f2e87dd662b6,
title = "Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model.",
abstract = "BACKGROUND: Inhibition of the proteasome-ubiquitin pathway has shown to exert growth inhibitory effects on several human carcinoma cell lines. In this study, the influence of bortezomib on human neuroblastoma cells was investigated. MATERIALS AND METHODS: Cell proliferation of seven human neuroblastoma cell lines under bortezomib treatment was assessed by a colorimetric XTT-based assay. Subsequently, the influence of bortezomib on SK-N-SH neuroblastoma cell growth was examined in a spontaneous metastatic SCID mouse model. RESULTS: In vitro, bortezomib inhibited proliferation of all cell lines in a dose-dependent manner. In the xenograft model, bortezomib treatment did not have an effect on the tumour weight, but induced apoptosis and reduced mitosis and angiogenesis, as well as the formation of pulmonary metastases. CONCLUSION: Bortezomib has anticancer effects on neuroblastoma cells in vitro and in a metastatic xenograft model. These findings provide a basis for further investigations of bortezomib in the treatment of metastasising neuroblastoma.",
author = "Ursula Valentiner and Christina Haane and Nina Nehmann and Udo Schumacher",
year = "2009",
language = "Deutsch",
volume = "29",
pages = "1219--1225",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

RIS

TY - JOUR

T1 - Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model.

AU - Valentiner, Ursula

AU - Haane, Christina

AU - Nehmann, Nina

AU - Schumacher, Udo

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Inhibition of the proteasome-ubiquitin pathway has shown to exert growth inhibitory effects on several human carcinoma cell lines. In this study, the influence of bortezomib on human neuroblastoma cells was investigated. MATERIALS AND METHODS: Cell proliferation of seven human neuroblastoma cell lines under bortezomib treatment was assessed by a colorimetric XTT-based assay. Subsequently, the influence of bortezomib on SK-N-SH neuroblastoma cell growth was examined in a spontaneous metastatic SCID mouse model. RESULTS: In vitro, bortezomib inhibited proliferation of all cell lines in a dose-dependent manner. In the xenograft model, bortezomib treatment did not have an effect on the tumour weight, but induced apoptosis and reduced mitosis and angiogenesis, as well as the formation of pulmonary metastases. CONCLUSION: Bortezomib has anticancer effects on neuroblastoma cells in vitro and in a metastatic xenograft model. These findings provide a basis for further investigations of bortezomib in the treatment of metastasising neuroblastoma.

AB - BACKGROUND: Inhibition of the proteasome-ubiquitin pathway has shown to exert growth inhibitory effects on several human carcinoma cell lines. In this study, the influence of bortezomib on human neuroblastoma cells was investigated. MATERIALS AND METHODS: Cell proliferation of seven human neuroblastoma cell lines under bortezomib treatment was assessed by a colorimetric XTT-based assay. Subsequently, the influence of bortezomib on SK-N-SH neuroblastoma cell growth was examined in a spontaneous metastatic SCID mouse model. RESULTS: In vitro, bortezomib inhibited proliferation of all cell lines in a dose-dependent manner. In the xenograft model, bortezomib treatment did not have an effect on the tumour weight, but induced apoptosis and reduced mitosis and angiogenesis, as well as the formation of pulmonary metastases. CONCLUSION: Bortezomib has anticancer effects on neuroblastoma cells in vitro and in a metastatic xenograft model. These findings provide a basis for further investigations of bortezomib in the treatment of metastasising neuroblastoma.

M3 - SCORING: Zeitschriftenaufsatz

VL - 29

SP - 1219

EP - 1225

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 4

M1 - 4

ER -